Clinical Trial Update: A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Sofosbuvir and Ribavirin in treatment-experienced adults with chronic he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir (ombitasvir/paritaprevir/ritonavir/dasabuvir)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-11-24